CN104321321B - 二环噻唑类化合物 - Google Patents

二环噻唑类化合物 Download PDF

Info

Publication number
CN104321321B
CN104321321B CN201380026183.8A CN201380026183A CN104321321B CN 104321321 B CN104321321 B CN 104321321B CN 201380026183 A CN201380026183 A CN 201380026183A CN 104321321 B CN104321321 B CN 104321321B
Authority
CN
China
Prior art keywords
thiazole
mixture
ylamino
carboxamide
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380026183.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN104321321A (zh
Inventor
泽匡明
森山英树
山田哲司
下重美纪
川濑裕介
宇野佑子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carna Biosciences Inc
National Cancer Center Korea
Original Assignee
Carna Biosciences Inc
National Cancer Center Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carna Biosciences Inc, National Cancer Center Korea filed Critical Carna Biosciences Inc
Publication of CN104321321A publication Critical patent/CN104321321A/zh
Application granted granted Critical
Publication of CN104321321B publication Critical patent/CN104321321B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CN201380026183.8A 2012-05-24 2013-05-22 二环噻唑类化合物 Expired - Fee Related CN104321321B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/479,396 US20130317218A1 (en) 2012-05-24 2012-05-24 Novel bicyclic thiazole compounds
US13/479,396 2012-05-24
PCT/JP2013/064960 WO2013176293A1 (en) 2012-05-24 2013-05-22 Novel bicyclic thiazole compounds

Publications (2)

Publication Number Publication Date
CN104321321A CN104321321A (zh) 2015-01-28
CN104321321B true CN104321321B (zh) 2017-07-07

Family

ID=48628877

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380026183.8A Expired - Fee Related CN104321321B (zh) 2012-05-24 2013-05-22 二环噻唑类化合物

Country Status (6)

Country Link
US (2) US20130317218A1 (https=)
EP (1) EP2855470B1 (https=)
JP (1) JP6095195B2 (https=)
KR (1) KR102042296B1 (https=)
CN (1) CN104321321B (https=)
WO (1) WO2013176293A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130317218A1 (en) 2012-05-24 2013-11-28 Masaaki Sawa Novel bicyclic thiazole compounds
WO2016202935A1 (en) * 2015-06-19 2016-12-22 Bayer Pharma Aktiengesellschaft Glucose transport inhibitors
JP6881309B2 (ja) * 2015-10-14 2021-06-02 日産化学株式会社 液晶配向剤、液晶配向膜、及び液晶表示素子
WO2024111626A1 (ja) * 2022-11-25 2024-05-30 カルナバイオサイエンス株式会社 新規チアゾール誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4038661B2 (ja) * 2002-05-21 2008-01-30 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
US8323943B2 (en) * 2008-02-21 2012-12-04 National Cancer Center Screening method for anticancer drug
US20100137386A1 (en) * 2008-12-01 2010-06-03 Tesshi Yamada Tnik inhibitor and the use
US20130317218A1 (en) 2012-05-24 2013-11-28 Masaaki Sawa Novel bicyclic thiazole compounds

Also Published As

Publication number Publication date
CN104321321A (zh) 2015-01-28
WO2013176293A1 (en) 2013-11-28
US20150133656A1 (en) 2015-05-14
KR102042296B1 (ko) 2019-11-07
EP2855470B1 (en) 2018-10-17
US9102637B2 (en) 2015-08-11
JP6095195B2 (ja) 2017-03-15
JP2015517453A (ja) 2015-06-22
EP2855470A1 (en) 2015-04-08
US20130317218A1 (en) 2013-11-28
KR20150014931A (ko) 2015-02-09

Similar Documents

Publication Publication Date Title
DK2890683T3 (en) MERGED BICYCLIC SULFAMOYL DERIVATIVES AND THEIR USE AS MEDICINES TO TREAT HEPATITIS B
CA2524401C (en) Thiazole derivatives as inhibitors of phosphatidylinositol 3-kinase
CN101103033B (zh) 作为pde2抑制剂的三唑并酞嗪
US20040229889A1 (en) HDAC inhibitor
CN108290897A (zh) 一类取代三唑并哌嗪类parp抑制剂及其制备方法和用途
AU2014267235A1 (en) Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
AU2021269397B2 (en) Compounds and compositions for the treatment of cancer
JP2010511727A5 (https=)
JP2018500372A (ja) B型肝炎感染症治療のための誘導体及び方法
EP2137158A1 (en) Small molecule inhibitors of protein arginine methyltransferases (prmts)
CN1964944A (zh) 作为抗病毒药的吲哚衍生物
NZ572660A (en) Novel piperazine compound, and use thereof as HCV polymerase inhibitor
CN103058949A (zh) 做为dhodh抑制剂的噻唑衍生物及其应用
CN101415704A (zh) 作为plk1抑制剂的4-苯基-噻唑-5-羧酸和4-苯基-噻唑-5-羧酸酰胺
CN104321321B (zh) 二环噻唑类化合物
US20090203692A1 (en) Novel chemical compounds
KR20080082970A (ko) 2-카르바미드-4-페닐티아졸 유도체, 그의 제법 및 그의치료 용도
JP2024540217A (ja) プロテインキナーゼ、特には、dyrk1a、clk1及び/又はclk4、の阻害剤としてのイミダゾロン誘導体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170707

Termination date: 20200522